MCT2D’s endocrinology initiative focuses on optimizing guideline-directed medical therapy, leveraging advanced technologies such as continuous glucose monitoring, and integrating low-carb diets into personalized care plans for type 2 diabetes.
The Michigan Collaborative for Type 2 Diabetes brings together primary care, endocrinology, and nephrology teams to collaborate in statewide quality improvement. Currently, 26 Michigan endocrinology practices participate in the collaborative.
Participating endocrinology practices attend the MCT2D spring regional meetings along with primary care and nephrology practices and have an endocrinology-specific meeting each fall to review the data and discuss endocrinology-focused topics with their peers.
Currently, 83 endocrinologists across the state participate in MCT2D, representing 49% of all endocrinologists in Michigan. MCT2D has developed an attribution model to assign patients to their endocrinologists in the MCT2D patient dashboards and aims to incorporate this in 2025.
New classes of medications improve glucose control, decrease mortality, slow chronic kidney disease progression, and support weight loss.
Promoting Low Carbohydrate Eating Patterns
Lower carbohydrate eating patterns may slow or reverse the progression of type 2 diabetes and be more effective than low-fat diets in patients who are trying to lose weight.
Endocrinology Leadership
Kara Mizokami-Stout, MD, MS
Endocrinology Program Director
Dr. Kara Mizokami-Stout, MD, MSc is an Assistant Professor of Internal Medicine in the Division of Metabolism, Endocrinology and Diabetes at the University of Michigan and the Lieutenant Colonel Charles S. Kettles VA Medical Center in Ann Arbor, MI. Dr. Mizokami-Stout’s clinical interests include type 1 and type 2 diabetes. Her research interests include diabetes health services research with a particular focus on 1) prevention and management of diabetes complications and 2) implementing technologies to improve diabetes self-management and quality-of-life.
Dr. Lynn Ang is a board-certified endocrinologist and Clinical Associate Professor in the Division of Metabolism, Endocrinology, and Diabetes within the Department of Internal Medicine at the University of Michigan. She serves as a co-director of the Hospital Intensive Insulin Program and chairs the Inpatient Glycemic Management Subcommittee. Her clinical and research interests include optimizing the management of hyperglycemia in both inpatient and outpatient settings, developing protocols for hospital glycemic guidelines, identifying biomarkers to predict the development or progression of diabetic complications, and detecting the earliest stages of these complications to prevent disease progression.
Dr. Jennifer Iyengar, MD is a board-certified endocrinologist and Clinical Associate Professor at the University of Michigan in the division of Metabolism, Endocrinology, & Diabetes. She is the Primary Quality Improvement Person (PQuIP) for the Michigan Medicine (MM) endocrinology division and serves as a member of the MM Internal Medicine Quality Council and the MM Outpatient Diabetes Quality Improvement (QI) Committee.
2024 Endocrinology & Primary Care Care Coordination QI Project, led by Dr. Jamal Hammoud, MD, of Endocrine Consultants of Mid Michigan and Dr. Farhan Khan, MD, of Farhan Khan MD PC.
2024 Endocrinology & Primary Care Care Coordination QI Project, led by Dr. Elizabeth Marshall and Dr. Zeina Habib of CMU Health Department of Endocrinology.
2024 Endocrinology & Primary Care Care Coordination QI Project, led by Dr. Vivek Variar and Dr. Nicholas Katcher of CMU Health Endocrinology and CMU Health Primary Care.
2024 Endocrinology & Primary Care Care Coordination QI Project, led by Dr. Amena Iqbal, MD; Dr. Sharon Deskins, MD; Michael Rivette of Corewell Health Royalton Diabetes & Endocrinology and Corewell Health Primary Care Royalton.
2024 Endocrinology & Primary Care Care Coordination QI Project, led by Dr. Anita Repp, MCT2D Endocrinology Clinical Champion, of Ann Arbor Diabetes and Endocrinology Associates; Anna Harris, HVPA Senior Analyst, Practice Coach; Dr. William Chavey, Emmaus Health Partners.
2024 Endocrinology & Primary Care Care Coordination QI Project, led by Heidi Diez, PharmD, of University of Michigan Health Domino's Farms Family Medicine; Christine Hagar, MS, RDN, CDCES; Laura Petersen, MHSA; Jennifer Wyckoff, MD.
Once per month we deliver news, updates, events, and more directly to you!
ccteam@mct2d.org
Support for The Michigan Collaborative for Type 2 Diabetes (MCT2D) is provided by Blue Cross Blue Shield of Michigan as part of the BCBSM Value Partnerships program.
Although Blue Cross Blue Shield of Michigan and MCT2D work collaboratively, the opinions, beliefs and viewpoints expressed by the author do not necessarily reflect the opinions, beliefs and viewpoints of BCBSM or any of its employees.